The brain targeted delivery of programmed cell death 4 specific siRNA protects mice from CRS-induced depressive behavior

Yufeng Jia,Xiao Zhuang,Yi Zhang,Ming Zhao,Nuo Chen,Wen Li,Faliang Zhu,Chun Guo,Yan Li,Qun Wang,Yuan Li,Lining Zhang
DOI: https://doi.org/10.1038/s41419-021-04361-9
2021-01-01
Abstract:Depression is one of the most common psychiatric disorders. Recently, studies demonstrate that antidepressants generating BDNF not only maintain synaptic signal transmission but also repress neuroinflammatory cytokines such as IL-6 and IL-1β. Therefore, promoting BDNF expression provides a strategy for the treatment of depression. Our recent research has indicated that programmed cell death 4 (Pdcd4) is a new target for antidepressant treatment by facilitating BDNF. Herein, we modified Pdcd4 specific small interfering RNA (siPdcd4) with the rabies virus glycoprotein peptide (RVG/siPdcd4) which enables it cross the blood-brain barrier (BBB). We found that RVG/siPdcd4 complex was selectively delivered to neurons and microglia and silenced the expression of Pdcd4, thereby up-regulating the level of BDNF and down-regulating IL-6 and IL-1β expression. More importantly, RVG/siPdcd4 injection attenuated synaptic plasticity impairment and protected mice from CRS-induced depressive behavior. These findings suggest that RVG/siPdcd4 complex is a potential therapeutic medicine for depression.
What problem does this paper attempt to address?